Ionis Pharmaceuticals Q4 Revenue Growth Exceeds Guidance, Forecasts Over $600 Million In 2025 Sales

On Wednesday, Ionis Pharmaceuticals Inc IONS reported a fourth-quarter EPS loss of $0.66, up from a loss of$0.06, beating the consensus of a $1.10 loss.The company reported an adjusted net loss of$68 million versus a net income of $17 million.Ionis reported quarterly sales of$227 million, down from $325 million a year ago, beating the consensus of$137.6 million.Ionis says 2024 revenue of $705 million exceeded guidance as the company continued to generate revenue from diverse sources. The company added n ...